Structured Summary
Abstract
Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. Mutations in the gene for factor XII that appear to increase factor XII amidolytic activity are associated with HEREDITARY ANGIOEDEMA TYPE III.
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
4 entry terms
- Coagulation Factor XII
- Factor 12
- Factor Twelve
- Hageman Factor
MeSH Record
Aspects Covered
28 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, cerebrospinal fluid, chemical synthesis, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
66(64)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Factor XII. Medical Subject Headings (MeSH). 2026. Unique ID D005174. http://id.nlm.nih.gov/mesh/2026/D005174
- Factor XII. In: Wikipedia. https://en.wikipedia.org/wiki/Factor_XII
- Factor XII. In: Wikidata. https://www.wikidata.org/wiki/Q339499